Nymox Pharmaceutical
NYMX
#10799
Rank
C$25.52 M
Marketcap
Country
C$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.93 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$9.13 Million, an increase over its 2021 earnings that were of -C$17.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.93 Million-67.99%
2022 -C$9.13 Million-47.71%
2021 -C$17.46 Million6.61%
2020 -C$16.37 Million-10.91%
2019 -C$18.38 Million24.24%
2018 -C$14.79 Million-20.03%
2017 -C$18.5 Million2.71%
2016 -C$18.01 Million-63.86%
2015 -C$49.83 Million674.44%
2014 -C$6.44 Million-6.11%
2013 -C$6.86 Million-35.66%
2012 -C$10.66 Million-20.76%
2011 -C$13.45 Million38.33%
2010 -C$9.72 Million35.59%
2009 -C$7.17 Million11.8%
2008 -C$6.41 Million-12.94%
2007 -C$7.37 Million8.85%
2006 -C$6.77 Million36.5%
2005 -C$4.96 Million-4.4%
2004 -C$5.19 Million-14.58%
2003 -C$6.07 Million
2001 -C$4.46 Million-20.54%
2000 -C$5.61 Million21.72%
1999 -C$4.61 Million-25.56%
1998 -C$6.19 Million101.3%
1997 -C$3.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.32 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.80 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.37 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.51 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.92 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA